Table 5.
Value of PET/CT scanning to assess a residual mass after completion of planned chemotherapy for Hodgkin lymphoma (HL) and aggressive nonHodgkin lymphoma (NHL)
View large
Value of PET/CT scanning to assess a residual mass after completion of planned chemotherapy for Hodgkin lymphoma (HL) and aggressive nonHodgkin lymphoma (NHL)

PFS indicates progression-free survival; nr, not reported.

*63 of 66 patients with a positive scan received subsequent radiation.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal